Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tilapia Skin for Pediatric Burns
NCT04391582Phase 2Completed
- Start
- May 2017
- Primary completion
- Apr 2018
- Modality
- Device-based Delivery
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of Nile tilapia skin xenograft in burn injury (2 arms). Primary endpoints: Complete burn wound healing at Day 11, Assessment of pain via the Faces Pain Scale-Revised (FPS-R) at Day 11 and 2 more. Started May 2017; status: completed.
02
Drugs
Nile tilapia skin xenograft
03
Conditions
burn injury
Beyond the preview
Go deeper on NCT04391582.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04391582.